We are live on
!
Find out more
SEP
Signature Equity Partners Portfolio holdings
AUM
$218M
Turnover
19.28%
This Fund
S&P 500
This Quarter
Est. Return
+17.82%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
+$31.5M
(+17%)
Cap. Flow
+$10.7M
Cap. Flow
% of AUM
4.92%
Top 10 Holdings %
Top 10 Hldgs %
24.17%
Holding
1,727
New
177
Increased
579
Reduced
510
Closed
156
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB Disruptors ETF
FWD
|
+$3.04M |
| 2 |
Apple
AAPL
|
+$1.95M |
| 3 |
Amazon
AMZN
|
+$1.49M |
| 4 |
First Trust Multi-Strategy Alternative ETF
LALT
|
+$1.45M |
| 5 |
JPMorgan International Value ETF
JIVE
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price Capital Appreciation Equity ETF
TCAF
|
+$1.6M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.58M |
| 3 |
Cambria Global Value ETF
GVAL
|
+$1.19M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03M |
| 5 |
American Beacon GLG Natural Resources ETF
MGNR
|
+$792K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.06% |
| 2 | Technology | 17.06% |
| 3 | Industrials | 6.38% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
RELX
RELX
$66.7B
| $7.35K | ﹤0.01% |
232
| – | – |
2025 Q4
2 quarters
|
|
902
CVS Health
CVS
$118B
| $7.34K | ﹤0.01% |
71
+12
| +20% | +$1.07K |
2025 Q4
2 quarters
|
|
903
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $7.34K | ﹤0.01% |
27
| – | – |
2025 Q4
2 quarters
|
|
904
Devon Energy
DVN
$54.4B
| $7.34K | ﹤0.01% |
178
+27
| +18% | +$1.25K |
2025 Q4
2 quarters
|
|
905
Bahl & Gaynor Small/Mid Cap Income Growth ETF
SMIG
$1.43B
| $7.32K | ﹤0.01% |
223
| – | – |
2025 Q4
2 quarters
|
|
906
Labcorp
LH
$26.2B
| $7.3K | ﹤0.01% |
26
+10
| +63% | +$2.63K |
2025 Q4
2 quarters
|
|
907
Genpact
G
$6.25B
| $7.29K | ﹤0.01% |
265
-69
| -21% | -$2.27K |
2025 Q4
2 quarters
|
|
908
Churchill Downs
CHDN
$5.74B
| $7.26K | ﹤0.01% |
81
+79
| +3,950% | +$7.08K |
2025 Q4
2 quarters
|
|
909
Inspire Medical Systems
INSP
$1.99B
| $7.23K | ﹤0.01% |
+162
| New | +$7.68K |
2026 Q2
0 quarters
|
|
910
Albemarle
ALB
$11.5B
| $7.17K | ﹤0.01% |
53
-57
| -52% | -$10.1K |
2025 Q4
2 quarters
|
|
911
iShares CMBS ETF
CMBS
$436M
| $7.05K | ﹤0.01% |
145
-153
| -51% | -$7.45K |
2025 Q4
2 quarters
|
|
912
Sysco
SYY
$40.5B
| $7.05K | ﹤0.01% |
84
-2,146
| -96% | -$162K |
2025 Q4
2 quarters
|
|
913
Huntington Ingalls Industries
HII
$10.5B
| $7.03K | ﹤0.01% |
25
-22
| -47% | -$7.35K |
2025 Q4
2 quarters
|
|
914
Oklo
OKLO
$5.44B
| $7.01K | ﹤0.01% |
134
+35
| +35% | +$2.18K |
2025 Q4
2 quarters
|
|
915
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3B
| $6.93K | ﹤0.01% |
237
| – | – |
2025 Q4
2 quarters
|
|
916
Weatherford International
WFRD
$5.31B
| $6.88K | ﹤0.01% |
84
-105
| -56% | -$10.7K |
2025 Q4
2 quarters
|
|
917
Cognex
CGNX
$9.3B
| $6.88K | ﹤0.01% |
95
-32
| -25% | -$1.94K |
2026 Q1
1 quarter
|
|
918
ENI
E
$82.7B
| $6.84K | ﹤0.01% |
146
+29
| +25% | +$1.55K |
2025 Q4
2 quarters
|
|
919
iShares Short Maturity Bond ETF
NEAR
$5.09B
| $6.84K | ﹤0.01% |
135
+1
| +0.7% | +$51 |
2026 Q1
1 quarter
|
|
920
Viking Holdings
VIK
$37.1B
| $6.8K | ﹤0.01% |
+65
| New | +$5.62K |
2026 Q2
0 quarters
|
|
921
Veeva Systems
VEEV
$50.5B
| $6.74K | ﹤0.01% |
38
-13
| -25% | -$2.14K |
2025 Q4
2 quarters
|
|
922
Applied Industrial Technologies
AIT
$12.2B
| $6.66K | ﹤0.01% |
20
+5
| +33% | +$1.53K |
2025 Q4
2 quarters
|
|
923
C.H. Robinson
CHRW
$16.5B
| $6.6K | ﹤0.01% |
35
+30
| +600% | +$5.33K |
2025 Q4
2 quarters
|
|
924
Jabil
JBL
$29.7B
| $6.55K | ﹤0.01% |
17
+5
| +42% | +$1.73K |
2025 Q4
2 quarters
|
|
925
Cleveland-Cliffs
CLF
$6.89B
| $6.48K | ﹤0.01% |
690
-512
| -43% | -$5.63K |
2025 Q4
2 quarters
|
|
Similar funds
FFL
CA
JCA
GIO
XWL
LCWM
TCM
RFO
Signature Equity Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Signature Equity Partners held 1,727 positions worth $218M, up 17% from $186M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Signature Equity Partners deployed $10.7M of net new capital in Q2 2026, opening 177 new positions and adding to 579 existing holdings. Its largest new stake was AB Disruptors ETF: 22,901 shares worth $3.39M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was T. Rowe Price Capital Appreciation Equity ETF, an estimated $1.6M trimmed.
- Signature Equity Partners's largest Q2 2026 buy was AB Disruptors ETF: 22,901 shares worth $3.39M.
- Signature Equity Partners added most to Apple in Q2 2026, an estimated $1.95M increase.
- Signature Equity Partners's biggest Q2 2026 reduction was T. Rowe Price Capital Appreciation Equity ETF, cutting an estimated $1.6M.
- Signature Equity Partners fully exited State Street US Sector Rotation ETF in Q2 2026, selling an estimated $169K.
- Signature Equity Partners's ten largest holdings make up 24% of its $218M portfolio in Q2 2026.
- Signature Equity Partners opened 177 new positions and closed 156 in Q2 2026.
- Signature Equity Partners's portfolio value rose 17% quarter-over-quarter to $218M.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.